Interactions of antimicrobial combinations in vitro: the relativity of synergism.
about
Synergy of an investigational glycopeptide, LY333328, with once-daily gentamicin against vancomycin-resistant Enterococcus faecium in a multiple-dose, in vitro pharmacodynamic modelFractional maximal effect method for in vitro synergy between amoxicillin and ceftriaxone and between vancomycin and ceftriaxone against Enterococcus faecalis and penicillin-resistant Streptococcus pneumoniae.Prediction of the effects of inoculum size on the antimicrobial action of trovafloxacin and ciprofloxacin against Staphylococcus aureus and Escherichia coli in an in vitro dynamic model.Use of pharmacodynamic indices to predict efficacy of combination therapy in vivo.Net effect of inoculum size on antimicrobial action of ampicillin-sulbactam: studies using an in vitro dynamic model.
P2860
Interactions of antimicrobial combinations in vitro: the relativity of synergism.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh-hant
name
Interactions of antimicrobial combinations in vitro: the relativity of synergism.
@en
Interactions of antimicrobial combinations in vitro: the relativity of synergism.
@nl
type
label
Interactions of antimicrobial combinations in vitro: the relativity of synergism.
@en
Interactions of antimicrobial combinations in vitro: the relativity of synergism.
@nl
prefLabel
Interactions of antimicrobial combinations in vitro: the relativity of synergism.
@en
Interactions of antimicrobial combinations in vitro: the relativity of synergism.
@nl
P1476
Interactions of antimicrobial combinations in vitro: the relativity of synergism.
@en
P2093
P577
1990-01-01T00:00:00Z